Abstract
Alpha1-protease inhibitor (alpha1-PI) deficiency is a well-recognized cause of emphysema in adults; howerver, the natural history of this disorder in children is unclear. Because of the paucity of data in the paediatric age group, we performed whole body plethysmography, spirometry, and diffusing capacity, in a cohort of 17 homozygous (PiZZ phenotype) children (9 females, 8 males; mean age ± SEM 13.4±0.9, range 7–18 years) and in 17 normal school-children (13.5±0.9, 7–18 years), using a matched-pair design. Blood was drawn for determination of serum alpha1-PI levels, PI phenotype, and standard biochemical tests of liver function. Among the PiZZ subjects, 12 were detected during diagnostic workup of prolonged neonatal icterus, and 5 by routine testing in paediatric patients. None had chronic respiratory symptoms except for an 18-year-old PiZZ girl with a history of recent onset of exertional dyspnoea. All were non-smokers. The Wilcoxon test was used for statistical analysis. As expected, serum alpha1-PI levels were lower in the PiZZ group (16% of the control value). A few patients had slight elevations of their liver enzymes. As for the pulmonary function parameters, differences between groups were not significant. Individual data showed no consistent abnormality in lung function except for signs of mild expiratory obstructive airway disease with hyperinflation (elevated TGV/TLC ratio) in the only symptomatic 18-year-old subject (0.63, control subject 0.49). This was unresponsive to bronchodilators. For her, augmentation therapy with intravenous infusions of alpha1-PI may be considered.
Similar content being viewed by others
Abbreviations
- Alpha 1-PI :
-
alpha1-protease inhibitor
- FEV 1 :
-
foreed expiratory volume in 1 s
- FRC :
-
functional residual capacity
- FVC :
-
forced vital capacity
- MEF :
-
maximal expiratory flow
- PEF :
-
peak expiratory flow
- TGV :
-
thoracic gas volume
- TLC :
-
total lung capacity
References
American Thoracic Society (1989) Guidelines for the approach to the patient with severe hereditary alpha-I-antitrypsin deficiency. Am Rev Respir Dis 140:1494–1497
Bimer P, McElvaney NG, Chang-Stroman LM, Crystal RG (1991) Alpha-1-antitrypsin deficiency and liver disease. J Inherited Metab Dis 14:512–525
Brantly ML, Paul LD, Miller BH, Falk RT, Wu M (1988) Clinical features and history of the destructive lung discase associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 138: 327–336
Buist AS, Adams BE, Azzam AH, Sexton GJ (1980) Pulmonary function in young children with alpha-1-antitrypsin deficiency. Am Rev Respir Dis 122:817–822
Buist AS, Burrows B, Erikson S, Mittman C, Wu M (1983) The natural history of air-flow obstruction in PiZ emphysema. Am Rev Respir Dis 127 [Suppl 2]:43–45
Dunand P, Cropp GJA, Middleton E (1976) Severe obstructive lung disease in a 14-year-old girl with alpha-1-antitrypsin deficiency. J Allergy Clin Immunol 57:615–622
Fagerhol MK, Cox DW (1981) The Pi polymorphism: genetic, biochemical and clinical aspects of human alpha-1-antitrypsin. Adv Hum Gen 11:1–62
Glasgow JF, Lynch MJ, Herez A, Levison H, Saas-Kortsak A (1973) α-1-antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs. Am J Med 54: 181–194
Hardt H von der, Nowak-Beneke R (1976) Lung volumes in healthy boys and girls, 6–15 years of age. Lung 154: 51–63
Hird MF, Greenough A, Mieli-Vergani G, Mowat AP (1991) Hyperinflation in children with liver disease due to alpha-1-antitrypsin deficiency. Pediatr Pulmonol 11:212–216
Houštek J, Copová M, Zapletal A, Tomášová H, Samánek M (1973) Alpha-1-antitrypsin deficiency in a child with chronic lung disease. Chest 64: 773–776
Janus ED, Phillips NT, Carrell RW (1985) Smoking, lung function, and alpha-1-antitrypsin deficiency. Lancet 8421:152–154
Larsson C (1978) Natural history and life expectancy in severe α-1-antitrypsin deficiency. PiZ. Acta Med Scand 204:345–351
Laurell CB, Eriksson S (1963) The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Invest 15:132–140
Levine BW, Shannon DC, Talamo RC, Kazemi H (1970) Alteration in distribution of pulmonary blood flow. An early manifestation of alpha-1-antitrypsin-deficiency. Ann Intern Med 73:397–401
Quanjer PH (1983) Standardized lung function testing. Report working party “Standardization of lung function tests”. Chapter 7: summary equations of reference values. European Community for Coal and Steel, Luxembourg. Bull Europ Physiopath Resp 19 [Suppl 5] 45–51
Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G (1989) Compilation of reference values for lung function measurements in children. Eur Respir J 2 [Suppl 4]:184s-261s
Silverman EK, Pierce JA, Province MA, Rao DC, Campbell EJ (1989) Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Ann Intern Med 111:982–991
Talamo RC, Levison H, Lynch MJ, Herez A, Hyslop NE, Bain HW (1971) Symptomatic pulmonary emphysema in childhood associated with herediatary alpha-1-antitrypsin and elastase inhibitor deficiency. J Pediatr 79:20–26
Wagener JS, Sobonya RE, Taussig LM, Lemen RJ (1983) Unusual abnormalities in adolescent siblings with alpha-1-antitrypsin deficiency. Chest 83:464–468
Wall M, Moe E, Eisenberg J, Powers M, Buist N, Buist AS (1990) Longterm follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr 116:248–251
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wiebicke, W., Niggemann, B. & Fischer, A. Pulmonary function in children with homozygous alpha1-protease inhibitor deficiency. Eur J Pediatr 155, 603–607 (1996). https://doi.org/10.1007/BF01957913
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957913